Because prostate cancer grows slowly and produces few symptoms, treatment is effective if detected early. Thanks to the prostate specific antigen (PSA) test, men are being diagnosed earlier, and there has been a decrease in the prostate cancer death rate.

As one of the few sites in the area with the new UroNav biopsy system, we can now identify and analyze suspicious prostate lesions with heightened precision and less trauma. Candidates have rising PSA levels and previously negative biopsies or are on active surveillance.

As the first facility on the east coast with CyberKnife, the hospital’s experts have administered nearly 18,000 CyberKnife treatments to tumors of the brain, head and neck, spine, lungs, prostate, pancreas and liver.